Managing Start-Up Costs in Tough Times: Non-legal Services
This article was originally published in Start Up
In addition to saving money on lawyers, can one save money on other service providers without sacrificing quality? Yes, tough economic times have motivated all service firms to be more reasonable. But it's also motivated many of them to try to offload costs onto existing, inattentive clients in order to cover overhead that used to be paid by a larger group of customers. Thus, active management of expenses is critical.
You may also be interested in...
Is there an explanation for the recent spate of biotech Phase II and Phase III clinical trial failures? It's almost impossible to give general reasons for specific clinical failures. Several hypotheses, borrowed from the tenets of behavioral finance, however, may help explain some recent, unanticipated later-stage setbacks. They may also support other studies that suggest that small biotech companies fail more often in clinical development than their larger biotech and pharma brethren.
Venture-backed biotech companies are increasingly seeking to commercialize drugs that qualify for orphan drug protection from the FDA; is this business model a good idea?
Biomarkers are being used now across the whole pharmaceutical value chain, but it's unlikely we'll see a surge in the number of VC-backed biomarker discovery start-ups until the business models are proven.